A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 14.12%. However, over the last six months, the performance has been weaker by 6.78%. The price of TAK increased 0.47% over the last 30 days. And in the last five days, it has surged by 3.14%.
Takeda Pharmaceutical Co ADR’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $15.37 on 04/03/25, with the lowest value being $12.57 on 06/20/24.
52-week price history of TAK Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Takeda Pharmaceutical Co ADR’s current trading price is -1.69% away from its 52-week high, while its distance from the 52-week low is 20.16%. The stock’s price range for this period has been between $12.57 and $15.37. The Healthcare sector company’s shares saw a trading volume of about 2.81 million for the day, which was higher than the average daily volume of 1.95 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Takeda Pharmaceutical Co ADR (TAK) has experienced a quarterly rise of 16.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 47.90B and boasts a workforce of 49281 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.99, with a change in price of +1.67. Similarly, Takeda Pharmaceutical Co ADR recorded 1,876,578 in trading volume during the last 100 days, posting a change of +12.43%.
TAK’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TAK stands at 0.65. Similarly, the long-term debt-to-equity ratio is also 0.63.
TAK Stock Stochastic Average
As of today, the raw stochastic average of Takeda Pharmaceutical Co ADR over the past 50 days is 88.10%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 85.31%. Additionally, the Stochastic %K and %D values for the company were 90.77% and 85.56%, respectively, over the past 20 days.
